☆ 4.7 Article

PDIA6, which is regulated by TRPM2-AS/miR-424-5p axis, promotes endometrial cancer progression via TGF-beta pathway

CELL DEATH & DISEASE (2023)

Related references

Note: Only part of the references are listed.

Article Cell Biology

TRPM2-AS promotes the malignancy of osteosarcoma cells by targeting miR-15b-5p/PPM1D axis

Yingchun Cai et al.

Summary: This study reveals that TRPM2-AS is overexpressed in OS cells and plays a detrimental role in cell viability, proliferation, and migration while inducing apoptosis. PPM1D is identified as a direct target of miR-15b-5p. The study demonstrates that TRPM2-AS promotes OS cell malignancy by interacting with miR-15b-5p/PPM1D axis.

CELL CYCLE (2022)

Add to Collection

Article Oncology

LncRNA-ZXF1 regulates P21 expression in endometrioid endometrial carcinoma by managing ubiquitination-mediated degradation and miR-378a-3p/PCDHA3 axis

Deshui Kong et al.

Summary: Long noncoding RNAs (lncRNAs) play a significant role in biological processes in various malignancies. This study focused on the role of lncRNA-ZXF1 in endometrial cancer and found that it acts as a tumor-suppressing lncRNA by regulating cell migration, invasion, and proliferation, potentially serving as a therapeutic, diagnostic, and prognostic indicator in the future.

MOLECULAR ONCOLOGY (2022)

Add to Collection

Review Cell Biology

TGF-β signaling: A recap of SMAD-independent and SMAD-dependent pathways

Sabreena Aashaq et al.

Summary: TGF-beta serves as a dual role in tumor progression, acting both as a tumor suppressor in the early stages and a metastatic promoter in the later stages. The signaling pathways of TGF-beta are complex, involving both SMAD-dependent and SMAD-independent pathways.

JOURNAL OF CELLULAR PHYSIOLOGY (2022)

Add to Collection

Article Gastroenterology & Hepatology

Inhibition of gastric cancer cell apoptosis by long noncoding RNA TRPM2-AS via mitogen-activated protein kinase and activators of transduction-3

Xianqin Zhang et al.

Summary: Through bioinformatics and quantitative polymerase chain reaction methods, it was confirmed that TRPM2-AS expression levels are upregulated in the GSE70880 dataset, TCGA database, and 26 GC tissues, partially induced by SP1. Clinical assays suggested that TRPM2-AS could potentially serve as an indicator for early-stage GC diagnosis. Functional experiments showed that knockdown of TRPM2-AS inhibited proliferation, migration, and invasion in GC cells, and promoted cell apoptosis.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2021)

Add to Collection

Article Cell Biology

LncRNA TRPM2-AS promotes ovarian cancer progression and cisplatin resistance by sponging miR-138-5p to release SDC3 mRNA

Yi Ding et al.

Summary: Our study found that the expression of TRPM2-AS and SDC3 was upregulated, while miR-138-5p was downregulated in OvC. TRPM2-AS and SDC3 promote the development of OvC, with TRPM2-AS sponging miR-138-5p to release SDC3, thus promoting OvC progression. Additionally, the TRPM2-AS/miR-1385p/SDC3 axis was closely associated with OvC tumorigenesis and cisplatin resistance.

AGING-US (2021)

Add to Collection

Article Biotechnology & Applied Microbiology

TRPM2-AS Promotes Bladder Cancer by Targeting miR-22-3p and Regulating GINS2 mRNA Expression

Yudong Tian et al.

Summary: This study revealed that TRPM2-AS is significantly upregulated in BLCA tissues and cell lines, with its knockdown inhibiting cell viability, proliferation, and colony formation while promoting apoptosis. miR-22-3p, a downstream target of TRPM2-AS, showed lower expression in BLCA and its inhibition enhanced cell phenotypes. Additionally, GINS2 mRNA, a downstream target of miR-22-3p, was upregulated in BLCA and its knockdown suppressed cell phenotypes, suggesting a novel interactome in BLCA with potential therapeutic implications.

ONCOTARGETS AND THERAPY (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Non-Coding RNAs as Prognostic Markers for Endometrial Cancer

Roberto Piergentili et al.

Summary: Endometrial cancer classification is evolving to include genetic and epigenetic features, with noncoding RNAs emerging as promising prognostic markers in the field.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Add to Collection

Article Biochemistry & Molecular Biology

MiR-501 promotes tumor proliferation and metastasis by targeting HOXD10 in endometrial cancer

Xiaomei Sun et al.

Summary: miR-501 is significantly up-regulated in endometrial cancer, associated with higher pelvic lymph node metastasis and shorter overall survival in high-grade endometrial cancer. Its high expression is also found in the copy-number-high group. Furthermore, miR-501 promotes tumor progression by directly targeting HOXD10 and activating the AKT/mTOR pathway.

CELLULAR & MOLECULAR BIOLOGY LETTERS (2021)

Add to Collection

Article Oncology

ZNF507 affects TGF-β signaling via TGFBR1 and MAP3K8 activation in the progression of prostate cancer to an aggressive state

Wookbong Kwon et al.

Summary: The study identified ZNF507 as a key regulator in the progression of prostate cancer to an aggressive state by upregulating the TGF-beta signaling pathway. ZNF507 was found to promote cell growth, survival, proliferation, and metastasis properties of prostate cancer, and positively regulated the transcription of genes such as TGFBR1, MAP3K8, and FURIN. These findings suggest that ZNF507 could be a promising target for studying the development of advanced metastatic prostate cancers.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)

Add to Collection

Article Medicine, Research & Experimental

Long non-coding RNA PCAT6 regulates bladder cancer progression via the microRNA-143-3p/PDIA6 axis

Yuanjie Zhang et al.

Summary: The study revealed that PCAT6 is upregulated in bladder cancer tissues and its silencing can inhibit cell proliferation, migration, and invasion. This effect may be mediated through the miR-143-3p/PDIA6 axis, suggesting a potential therapeutic target for bladder cancer treatment.

EXPERIMENTAL AND THERAPEUTIC MEDICINE (2021)

Add to Collection

Article Oncology

PDIA6 promotes pancreatic cancer progression and immune escape through CSN5-mediated deubiquitination of beta-catenin and PD-L1

Yihui Ma et al.

Summary: The study revealed that PDIA6 plays a crucial role in the progression of pancreatic cancer, with its overexpression promoting malignant characteristics of the cancer cells, while its knockdown leads to a reduction in these traits. Additionally, PDIA6 interacts with CSN5 and influences the deubiquitination of beta-catenin and PD-L1, suggesting PDIA6 as a potential target for pancreatic cancer treatment.

NEOPLASIA (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Long noncoding RNA CHL1-AS1 promotes cell proliferation and migration by sponging miR-6076 to regulate CHL1 expression in endometrial cancer

Yanmei Shi et al.

JOURNAL OF CELLULAR BIOCHEMISTRY (2020)

Add to Collection

Review Oncology

Noncoding RNAs as potential mediators of resistance to cancer immunotherapy

Radhakrishnan Vishnubalaj et al.

SEMINARS IN CANCER BIOLOGY (2020)

Add to Collection

Article Oncology

Cancer statistics, 2020

Rebecca L. Siegel et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2020)

Add to Collection

Article Oncology

Long noncoding RNA TRPM2-AS acts as a microRNA sponge of miR-612 to promote gastric cancer progression and radioresistance

Jian Xiao et al.

ONCOGENESIS (2020)

Add to Collection

Article Oncology

Long non-coding RNA TRPM2-AS sponges microRNA-138-5p to activate epidermal growth factor receptor and PI3K/AKT signaling in non-small cell lung cancer

Dong Cui et al.

ANNALS OF TRANSLATIONAL MEDICINE (2020)

Add to Collection

Article Medicine, General & Internal

PDIA6 modulates apoptosis and autophagy of non-small cell lung cancer cells via the MAP4K1/JNK signaling pathway

Yuxin Bai et al.

EBIOMEDICINE (2019)

Add to Collection

Review Oncology

Current recommendations and recent progress in endometrial cancer

Rebecca A. Brooks et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2019)

Add to Collection

Review Medicine, Research & Experimental

Long non-coding RNAs and endometrial cancer

Hongyang Liu et al.

BIOMEDICINE & PHARMACOTHERAPY (2019)

Add to Collection

Article Allergy

MicroRNA

Thomas X. Lu et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2018)

Add to Collection

Article Medicine, Research & Experimental

miR-137 is a tumor suppressor in endometrial cancer and is repressed by DNA hypermethylation

Wei Zhang et al.

LABORATORY INVESTIGATION (2018)

Add to Collection

Review Genetics & Heredity

Non-Coding RNAs and Endometrial Cancer

Cristina Vallone et al.

GENES (2018)

Add to Collection

Article Oncology

miR-652 Promotes Tumor Proliferation and Metastasis by Targeting RORA in Endometrial Cancer

Xiaomei Sun et al.

MOLECULAR CANCER RESEARCH (2018)

Add to Collection

Article Cell Biology

Non-Smad Signaling Pathways of the TGF-β Family

Ying E. Zhang

COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2017)

Add to Collection

Review Oncology

Molecular approaches for classifying endometrial carcinoma

Josep M. Piulats et al.

GYNECOLOGIC ONCOLOGY (2017)

Add to Collection

Review Biochemistry & Molecular Biology

Dysregulated expression of long noncoding RNAs in gynecologic cancers

Elahe Seyed Hosseini et al.

MOLECULAR CANCER (2017)

Add to Collection

Review Medicine, General & Internal

Stromal Modulators of TGF-β in Cancer

Brunella Costanza et al.

JOURNAL OF CLINICAL MEDICINE (2017)

Add to Collection

Article Oncology

The TGF-β signalling negative regulator PICK1 represses prostate cancer metastasis to bone

Yuhu Dai et al.

BRITISH JOURNAL OF CANCER (2017)

Add to Collection

Review Genetics & Heredity

Roles, Functions, and Mechanisms of Long Non-coding RNAs in Cancer

Yiwen Fang et al.

GENOMICS PROTEOMICS & BIOINFORMATICS (2016)

Add to Collection

Review Biochemistry & Molecular Biology

Structural determinants of Smad function in TGF-β signaling

Maria J. Macias et al.

TRENDS IN BIOCHEMICAL SCIENCES (2015)

Add to Collection

Article Multidisciplinary Sciences

Epigenetic regulation of Smad2 and Smad3 by profilin-2 promotes lung cancer growth and metastasis

Yun-Neng Tang et al.

NATURE COMMUNICATIONS (2015)

Add to Collection

Article Biochemistry & Molecular Biology

Antisense transcription at the TRPM2 locus as a novel prognostic marker and therapeutic target in prostate cancer

U. Orfanelli et al.

ONCOGENE (2015)

Add to Collection

Review Oncology

Long non-coding RNAs: A new frontier in the study of human diseases

Xuefei Shi et al.

CANCER LETTERS (2013)

Add to Collection

Review Obstetrics & Gynecology

Endometrial cancer: molecular and therapeutic aspects

Panagiotis Tsikouras et al.

EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2013)

Add to Collection

Review Oncology

TGFβ signalling: a complex web in cancer progression

Hiroaki Ikushima et al.

NATURE REVIEWS CANCER (2010)

Add to Collection

Article Cell Biology

Identification of novel sense and antisense transcription at the TRPM2 locus in cancer

Ugo Orfanelli et al.

CELL RESEARCH (2008)

Add to Collection

Article Oncology

Prospective determination of prevalence of lynch syndrome in young women with endometrial cancer

Karen H. Lu et al.

JOURNAL OF CLINICAL ONCOLOGY (2007)

Add to Collection

© Peeref 2019-2024. All rights reserved.